Canopy Growth Corporation Q2 2027 Earnings Call Summary
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Moby summary of Canopy Growth Corporation's Q2 2027 earnings call
Directly affected
- CGC Canopy Growth-19.8% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Canopy Growth belongs to, so it often moves with news about it.
- RGC Regencell Bioscience Holdings+17.2% 6d
Regencell Bioscience Holdings is a peer of Canopy Growth in medicinal chemicals and botanical products; rivals often move on the same news.
- DFTX Definium Therapeutics-10.8% 30d
Definium Therapeutics is a peer of Canopy Growth in medicinal chemicals and botanical products; rivals often move on the same news.
- LLY Eli Lilly and+19.9% 30d
Eli Lilly and is a large health company like Canopy Growth; big names in a sector often move together.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson is a large health company like Canopy Growth; big names in a sector often move together.
- ABBV AbbVie+11.3% 30d
AbbVie is a large health company like Canopy Growth; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| CGC | -3.28% | +5.10% | base | -9.82% | after close | after close | after close |
| XLV | -0.05% | -0.52% | base | +0.18% | after close | after close | after close |
| RGC | +26.14% | +18.56% | base | -1.42% | after close | after close | after close |
| DFTX | +19.79% | +10.10% | base | +7.40% | after close | after close | after close |
| LLY | +3.64% | +3.08% | base | +0.11% | after close | after close | after close |
| JNJ | +0.29% | -2.31% | base | +1.03% | after close | after close | after close |
| ABBV | +2.38% | -0.72% | base | +1.13% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Canopy Growth Corporation Q2 2027 Earnings Call Summary Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | +1.13% | still updating |
| ABBV | three days earlier | -0.72% | final price |
| ABBV | five days earlier | +2.38% | final price |
| CGC | that day | -9.82% | still updating |
| CGC | three days earlier | +5.10% | final price |
| CGC | five days earlier | -3.28% | final price |
| DFTX | that day | +7.40% | still updating |
| DFTX | three days earlier | +10.10% | final price |
| DFTX | five days earlier | +19.79% | final price |
| JNJ | that day | +1.03% | still updating |
| JNJ | three days earlier | -2.31% | final price |
| JNJ | five days earlier | +0.29% | final price |
| LLY | that day | +0.11% | still updating |
| LLY | three days earlier | +3.08% | final price |
| LLY | five days earlier | +3.64% | final price |
| RGC | that day | -1.42% | still updating |
| RGC | three days earlier | +18.56% | final price |
| RGC | five days earlier | +26.14% | final price |
| XLV | that day | +0.18% | still updating |
| XLV | three days earlier | -0.52% | final price |
| XLV | five days earlier | -0.05% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 63 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 37 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 42 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 59 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 53 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 63 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “Canopy Growth Corporation Q2 2027 Earnings Call Summary” looks
12 out of 100Price not final
“Canopy Growth Corporation Q2 2027 Earnings Call Summary” scores 12 out of 100. The score uses 1 sources. The price is not final yet.